Glaxo Said to Pay $460 Million to Settle Avandia  Suit

Glaxo Said to Pay $460 Million to Settle Avandia Suit

JB Reed/ Bloomberg

Glaxo is settling Avandia claims as a U.S. Food and Drug Administration advisory panel is meeting in Washington.